I respectfully disagree with Drs. Jha and Ware's concluding statement “The CNBSS is
compelling enough to never start mammograms for breast cancer but not compelling enough
to stop screening.” In addition, the assumption that “If the CNBSS was the first RCT
in screening for breast cancer, it is unlikely that screening would have been approved”
goes against our standard methods of critical review. Regardless of the order in which
data are published, we still have an obligation as scientists to uphold rigorous methodology
(
1
). Our clinical decisions are dependent upon this adherence to proper randomized controlled
trial design.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Academic RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The scandal of poor medical research.BMJ. 1994; 308: 283-284
- The Canadian National Breast Screening Study: a critical review.AJR Am J Roentgenol. 1993; 161: 755-760
- (Available at:) (Accessed October 16 2015)
Article info
Publication history
Published online: October 27, 2015
Identification
Copyright
© 2016 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
